SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
出版年份 2023 全文链接
标题
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
作者
关键词
-
出版物
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-03
DOI
10.1007/s00415-023-12034-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis
- (2023) Maria-Ioanna Stefanou et al. Multiple Sclerosis Journal
- Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs
- (2023) Rocco Capuano et al. Multiple Sclerosis Journal
- Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience
- (2023) Andrea Bertozzi et al. Multiple Sclerosis and Related Disorders
- Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study
- (2023) Niklas Frahm et al. Journal of Clinical Medicine
- Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
- (2022) Marton König et al. JAMA Neurology
- COVID‐19 vaccination hesitancy among people with chronic neurological disorders: A position paper
- (2022) Martin Rakusa et al. EUROPEAN JOURNAL OF NEUROLOGY
- COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
- (2022) Sapir Dreyer-Alster et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
- (2022) Rocco Capuano et al. Multiple Sclerosis and Related Disorders
- Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis
- (2022) Ethel Ciampi et al. Multiple Sclerosis and Related Disorders
- Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
- (2022) Carlos Quintanilla-Bordás et al. Frontiers in Neurology
- Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
- (2022) Agata Czarnowska et al. Vaccines
- Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
- (2022) Rocco Capuano et al. JOURNAL OF NEUROLOGY
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
- (2022) Dominika Stastna et al. Multiple Sclerosis and Related Disorders
- Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
- (2022) Lingyao Kong et al. Multiple Sclerosis and Related Disorders
- CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
- (2022) Virginia Rinaldi et al. Frontiers in Neurology
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- SARS-CoV-2 vaccines: a triumph of science and collaboration
- (2021) Jonathan L. Golob et al. JCI Insight
- Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
- (2021) Itay Lotan et al. EUROPEAN JOURNAL OF NEUROLOGY
- mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
- (2021) Massimiliano Di Filippo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021
- (2021) Dawn M. Ehde et al. Multiple Sclerosis and Related Disorders
- Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
- (2021) Giorgia T. Maniscalco et al. Frontiers in Neurology
- Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations
- (2021) Verónica Cabreira et al. Vaccines
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data
- (2021) Samantha Epstein et al. Multiple Sclerosis and Related Disorders
- Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases
- (2021) Riccardo Nistri et al. Frontiers in Neurology
- Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
- (2020) Hsin-I Shih et al. Biomedical Journal
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination in Multiple Sclerosis: Friend or Foe?
- (2019) Tobias Zrzavy et al. Frontiers in Immunology
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- The spectrum of post-vaccination inflammatory CNS demyelinating syndromes
- (2013) Dimitrios Karussis et al. AUTOIMMUNITY REVIEWS
- Immunizations and risk of multiple sclerosis: systematic review and meta-analysis
- (2011) Mauricio F. Farez et al. JOURNAL OF NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started